0
Predictive Oncology Inc. Banner Image

Predictive Oncology Inc. has reached its limit for free report views

Work for Predictive Oncology Inc.? Upgrade Your Profile and unlock all your annual reports.

Predictive Oncology Inc.

  • Ticker POAI
    Exchange NASDAQ More
  • Industry Medical Instruments & Supplies More
  • Sector Healthcare More
Predictive Oncology Inc. Logo Image
  • 11-50 Employees
  • Based in Eagan, Minnesota
Predictive Oncology (NASDAQ: POAI) operates through three segments (Domestic, International and other), which contain four subsidiaries; Helomics, TumorGenesis, Skyline Medical and Soluble Biotech. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies inMore collaborations with pharmaceutical companies. Helomics’ CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy. In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™, patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary bioinformatics platform to provide a tailored solution to its clients’ specific needs.
Predictive Oncology Inc.

Most Recent Annual Report

Predictive Oncology Inc. MOST RECENT 2020 Annual Report and Form 10K

Report Locked. Predictive Oncology Inc. has reached its limit for free report views.

Older/Archived Annual Reports